These data suggest that BCR/ABL1 is involved in the expression of Hsp32 in Ph+ ALL, whereas in Ph− ALL, other mechanisms contribute to Hsp32 expression. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.